论文部分内容阅读
Chronic hepatitis B infection is a serious and prevalent health concern worldwide, and the development of effective drugs and strategies to combat this disease is urgently needed.Currently, pegylated interferon-alpha (peg-IFNα) and nucleoside/nucleotide analogues (NA) are the most commonly prescribed treatments.